Prophylactic SSRI during interferon alpha re-therapy in patients with chronic hepatitis C and a history of interferon-induced depression.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMID 15655055)

Published in J Viral Hepat on January 01, 2005

Authors

M R Kraus1, A Schäfer, O Al-Taie, M Scheurlen

Author Affiliations

1: Medizinische Poliklinik (Clinic for Internal Medicine), University of Würzburg, Klinikstrasse, Würzburg, Germany. kraus_m@klinik.uni-wuerzburg.de

Articles citing this

Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Mol Psychiatry (2008) 1.80

Prophylactic antidepressant treatment in patients with hepatitis C on antiviral therapy: a double-blind, placebo-controlled trial. Psychosomatics (2010) 1.60

Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci (2009) 1.58

The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D). Mol Psychiatry (2012) 1.41

Determinants of antiviral treatment initiation in a hepatitis C-infected population benefiting from universal health care coverage. Can J Gastroenterol (2007) 1.21

Major depression during interferon-alpha treatment: vulnerability and prevention. Dialogues Clin Neurosci (2009) 0.92

Nutritional status, acute phase response and depression in metastatic lung cancer patients: correlations and association prognosis. Support Care Cancer (2011) 0.91

A functional serotonin transporter gene polymorphism and depressive effects associated with interferon-alpha treatment. Psychosomatics (2010) 0.88

Psychosocial issues in patients with chronic hepatitis B and C. Curr Health Sci J (2014) 0.85

Current therapy for hepatitis C. Int J Colorectal Dis (2005) 0.83

Psychiatric care of the patient with hepatitis C: a review of the literature. Prim Care Companion J Clin Psychiatry (2010) 0.82

Does prophylactic antidepressant treatment boost interferon-alpha treatment completion in HCV? World J Virol (2013) 0.81

Can antidepressants prevent pegylated interferon-α/ribavirin-associated depression in patients with chronic hepatitis C: meta-analysis of randomized, double-blind, placebo-controlled trials? PLoS One (2013) 0.80

Management of Adverse Events During the Treatment of Chronic Hepatitis C Infection. Clin Liver Dis (Hoboken) (2012) 0.78

Depression and suicide ideation in chronic hepatitis C patients untreated and treated with interferon: prevalence, prevention, and treatment. Ann Gastroenterol (2015) 0.77

Psychiatric Adverse Effects Of Interferon Therapy. Clujul Med (2013) 0.75

What psychiatric screening and monitoring might be needed with the new generation of hepatitis C treatments? World J Virol (2015) 0.75

Articles by these authors

Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential. Immunity (2000) 2.93

A novel pathway of DNA end-to-end joining. Cell (1990) 2.61

Therapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled study. Gut (2007) 1.75

Circular dichroism of ribonucleoprotein complexes from rat liver nuclei. Biochem Biophys Res Commun (1977) 1.69

Expression of the Bacillus subtilis sacB gene leads to sucrose sensitivity in the gram-positive bacterium Corynebacterium glutamicum but not in Streptomyces lividans. J Bacteriol (1992) 1.68

Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br J Pharmacol (1997) 1.48

Anal endosonography and manometry: comparison in patients with defecation problems. Dis Colon Rectum (1997) 1.46

Studies on the orientation of brush-border membrane vesicles. Biochem J (1978) 1.46

Accumulation of sulfoquinovosyl-1-O-dihydroxyacetone in a sulfolipid-deficient mutant of Rhodobacter sphaeroides inactivated in sqdC. Arch Biochem Biophys (1997) 1.44

[Morphologic studies of the placentas of HIV-positive mothers]. Pathologe (1988) 1.41

LAV/HTLV-III in 20-week fetus. Lancet (1985) 1.40

Comparison of anal sonography with conventional needle electromyography in the evaluation of anal sphincter defects. Am J Gastroenterol (1996) 1.40

Pentamidine and hypoglycaemia. Lancet (1989) 1.39

[Disseminated lymphangioleiomyomatosis]. Geburtshilfe Frauenheilkd (1992) 1.38

Spectroscopic evidence for the interaction of phalloidin with actin. FEBS Lett (1975) 1.28

Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C. Psychosomatics (2000) 1.16

Isometric contraction induces the Ca2+-independent activation of the endothelial nitric oxide synthase. Proc Natl Acad Sci U S A (1999) 1.15

Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: a family study. Scand J Gastroenterol (2001) 1.15

Ventricular arrhythmias in idiopathic dilated cardiomyopathy. Br Heart J (1984) 1.14

Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C. Aliment Pharmacol Ther (2002) 1.13

Expression of pyruvate kinase M2 in preneoplastic hepatic foci of N-nitrosomorpholine-treated rats. Virchows Arch (1999) 1.12

Isolation of insertion elements from gram-positive Brevibacterium, Corynebacterium and Rhodococcus strains using the Bacillus subtilis sacB gene as a positive selection marker. FEMS Microbiol Lett (1995) 1.11

Epidemiology of inflammatory bowel disease in the county of Tübingen (West Germany). Scand J Gastroenterol Suppl (1989) 1.08

Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group. Transplant Proc (1998) 1.05

Compliance with therapy in patients with chronic hepatitis C: associations with psychiatric symptoms, interpersonal problems, and mode of acquisition. Dig Dis Sci (2001) 1.04

The staphylococcal phosphoenolpyruvate-dependent phosphotransferase system. Purification and characterisation of the galactoside-specific membrane-component enzyme II. Eur J Biochem (1981) 1.04

On the effect of prostaglandins E2 and F2alpha on bronchial tonus in cats. Eur J Pharmacol (1974) 1.02

Low systemic exposure to tacrolimus correlates with acute rejection. Transplant Proc (1999) 0.99

Integration of narrow-host-range vectors from Escherichia coli into the genomes of amino acid-producing corynebacteria after intergeneric conjugation. J Bacteriol (1996) 0.98

Demonstration of HIV-1 infected cells in human placenta by in situ hybridisation and immunostaining. J Clin Pathol (1992) 0.98

Fast-growing gastric inflammatory pseudotumor: a rare manifestation of peptic ulcer disease. Endoscopy (2002) 0.98

Cavernous transformation of the portal vein associated with common bile duct strictures: report of two cases. Gastrointest Endosc (1998) 0.98

Successful treatment of a gastric leak after bariatric surgery using endoluminal vacuum therapy. Endoscopy (2013) 0.97

Pharmacokinetics of tacrolimus: clinically relevant aspects. Transplant Proc (1999) 0.97

Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients. Eur J Drug Metab Pharmacokinet (1999) 0.96

Oxprenolol absorption in man after single bolus dosing into two segments of the colon compared with that after oral dosing. Br J Clin Pharmacol (1985) 0.96

The disposition of 14C-labeled tacrolimus after intravenous and oral administration in healthy human subjects. Drug Metab Dispos (1999) 0.96

Primary structure differences of human surfactant-associated proteins isolated from normal and proteinosis lung. Biochim Biophys Acta (1992) 0.95

Pancreatic autoantibodies in Crohn's disease: a family study. Gut (1997) 0.94

The role of the Corynebacterium glutamicum rel gene in (p)ppGpp metabolism. Microbiology (1998) 0.94

Identification, cloning and sequencing of the replication region of Lactococcus lactis ssp. lactis biovar. diacetylactis Bu2 citrate plasmid pSL2. FEMS Microbiol Lett (1991) 0.93

The basal ganglia in haemochromatosis. Neuroradiology (2000) 0.93

Ezetimibe potently reduces vascular inflammation and arteriosclerosis in eNOS-deficient ApoE ko mice. Atherosclerosis (2008) 0.93

Cloning, nucleotide sequence, and overexpression of smoS, a component of a novel operon encoding an ABC transporter and polyol dehydrogenases of Rhodobacter sphaeroides Si4. J Bacteriol (1997) 0.92

Reconstitution of squamous epithelium in Barrett's oesophagus with endoscopic argon plasma coagulation: a prospective study. Scand J Gastroenterol (1998) 0.92

Spectral karyotype analysis of colon cancer cell lines of the tumor suppressor and mutator pathway. Cytogenet Genome Res (2002) 0.92

Hydrops fetalis: manifestation in lysosomal storage diseases including Farber disease. Eur J Pediatr (1997) 0.91

mARVCF cellular localisation and binding to cadherins is influenced by the cellular context but not by alternative splicing. J Cell Sci (2001) 0.91

Microbic superinfection in relapse of inflammatory bowel disease. J Clin Gastroenterol (1992) 0.90

SNP-Array genotyping and spectral karyotyping reveal uniparental disomy as early mutational event in MSS- and MSI-colorectal cancer cell lines. Cytogenet Genome Res (2007) 0.89

Structure and function of nuclear ribonucleoprotein complexes. Rev Physiol Biochem Pharmacol (1978) 0.89

Sonographic, manometric, and myographic evaluation of the anal sphincters morphology and function. Dis Colon Rectum (1993) 0.88

Expression pattern of gastrointestinal selenoproteins--targets for selenium supplementation. Nutr Cancer (1998) 0.88

Effect of breakfast on the oral bioavailability of tacrolimus and changes in pharmacokinetics at different times posttransplant in renal transplant recipients. Transplant Proc (1998) 0.88

Low molecular weight RNAs as components of nuclear ribonucleoprotein particles containing heterogeneous nuclear RNA. Biochim Biophys Acta (1979) 0.87

[The electron microscopic cytomorphology of gynecomastia]. Virchows Arch A Pathol Pathol Anat (1969) 0.87

Construction of L-lysine-overproducing strains of Brevibacterium lactofermentum by targeted disruption of the hom and thrB genes. Appl Microbiol Biotechnol (1996) 0.87

Isolation and characterization of a dibenzofuran-degrading yeast: identification of oxidation and ring cleavage products. Appl Environ Microbiol (1998) 0.86

The eNOS enhancer AVE 9488: a novel cardioprotectant against ischemia reperfusion injury. Basic Res Cardiol (2009) 0.86

Factors affecting mass transfer limited biodegradation in saturated porous media. J Contam Hydrol (2001) 0.86

Neurodevelopmental outcome after prenatal exposure to opiates. Eur J Pediatr (1998) 0.86

Impaired pancreatic function in patients with Crohn's disease with and without pancreatic autoantibodies. J Clin Gastroenterol (1996) 0.85

Inactivation of glyceraldehyde-3-phosphate dehydrogenase by a reactive metabolite of acetaminophen and mass spectral characterization of an arylated active site peptide. Chem Res Toxicol (1997) 0.85

[Electron-microscopic and experimental investigations of the morphology of gynaecomastia]. Verh Dtsch Ges Pathol (1968) 0.85

Growth control in mammalian cells by cell-cell contacts. Environ Health Perspect (1990) 0.84

What does elevated high-sensitive troponin I in stroke patients mean: concomitant acute myocardial infarction or a marker for high-risk patients? Cerebrovasc Dis (2013) 0.84

Infrequent neonatal opiate withdrawal following maternal methadone detoxification during pregnancy. J Perinat Med (1990) 0.84

Inverse mRNA expression of the selenocysteine-containing proteins GI-GPx and SeP in colorectal adenomas compared with adjacent normal mucosa. Nutr Cancer (2000) 0.84

A highly sensitive cytotoxicity assay based on the release of reporter enzymes, from stably transfected cell lines. J Immunol Methods (1997) 0.84

Paroxetine for the prevention of depression induced by interferon alfa. N Engl J Med (2001) 0.83

CPY* and the power of yeast genetics in the elucidation of quality control and associated protein degradation of the endoplasmic reticulum. Curr Top Microbiol Immunol (2005) 0.83

Correlation of immune defects in hemophilia with HTLV-III antibody titers. Vox Sang (1986) 0.83

Transmission of HIV-1 from productively infected mature Langerhans cells to primary CD4+ T lymphocytes results in altered T cell responses with enhanced production of IFN-gamma and IL-10. Virology (1996) 0.83

[Electron microscopic and histochemical studies of the morphology and function of myoepithelial cells]. Verh Dtsch Ges Pathol (1967) 0.82

[Phlegmonous gastritis in a 44-year-old woman on immunosuppressive therapy]. Dtsch Med Wochenschr (2007) 0.82

Vertical human immunodeficiency virus transmission: a study of placental pathology in relation to maternal risk factors. Am J Perinatol (1994) 0.82

The effect of chronic lithium application on the mineral content of rat bone and soft tissues. Int Pharmacopsychiatry (1975) 0.82

[Coparative photometric and electron microscopic studies on isolated rat brain mitochondria and microsomes in vitro under conditions of osmotic swelling and ATP-induced contraction]. Brain Res (1968) 0.82

Thermalization of strongly coupled field theories. Phys Rev Lett (2011) 0.82

[Progressive scleroderma and the terminal stage of malignant hypertension]. Arch Klin Med (1968) 0.82

An unusual mutation in the XPG gene leads to an internal in-frame deletion and a XP/CS complex phenotype. Br J Dermatol (2014) 0.81

[Severe hepatitis and subacute liver failure with "fast track" cirrhosis in an elderly lady]. Z Gastroenterol (2010) 0.81

Phalloidin counteracts the inhibitory effect of actin on deoxyribonuclease I. FEBS Lett (1975) 0.81

Comparative studies of the effects of galactosamine and actinomycin D on nuclear ribonucleoprotein particles from rat liver. Exp Cell Res (1977) 0.81

[Diagnosis and immunopathogenesis of secondary amyloidosis in man]. Med Welt (1965) 0.81

Resistance to cellular immune response in AKR leukemias. Eur J Immunol (1986) 0.80

Disseminated cytomegalovirus infection of the female genital tract. Gynecol Obstet Invest (1991) 0.80

Fetal organs infected by HIV-1. AIDS (1993) 0.80

Pharmacokinetics of FK 506 and mycophenolic acid after the administration of a FK 506-based regimen in combination with mycophenolate mofetil in kidney transplantation. Transplant Proc (1998) 0.80

An effective and safe protocol involving zidovudine and caesarean section to reduce vertical transmission of HIV-1 infection. AIDS (2000) 0.80

[An unusual case of suicidal carbon monoxide poisoning]. Arch Kriminol (1988) 0.80

[Risk factors of premature birth and their significance for prevention and health promotion--an analysis based on the BabyCare Program]. Gesundheitswesen (2003) 0.79

[Intraepithelial spread of the squamous cell carcinoma of the uterine cervix into the endometrium. A contribution to the question of a surface spread of the cervical carcinoma]. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1977) 0.79